Aflatoxin is a group of mycotoxins which are produced by *Aspergillus* spp., especially *A. flavus*, *A. parasiticus* and *A. nomius* \[[@r18]\]. This health hazardous toxin can be found as a contaminant in agricultural commodities during cultivation, harvesting, transport and storage in various regions with hot and humid climates \[[@r2], [@r18], [@r47]\]. Aflatoxin B~1~ (AFB~1~) is the most potent hepatotoxic agent which causes histopathological changes of liver such as necrosis, vacuolar degeneration, fatty changes, megalocytosis and binucleation of hepatocyte. Furthermore, bile duct hyperplasia and periportal fibrosis are observed \[[@r1], [@r2], [@r48], [@r49]\]. During AFB~1~ metabolism activated by cytochrome P450, the reactive oxygen species (ROS), such as superoxide ion (O~2~^−^) and hydrogen peroxide (H~2~O~2~), are produced excessively leading to oxidative stress that could be eradicated by antioxidants \[[@r27], [@r44]\]. However, the overwhelming oxidative stress beyond an ability of antioxidants to handle results in damage of critical macromolecules (lipid, DNA and protein) and loss of biological functions such as calcium influx, membrane leakage and consequently affected DNA stability that leads to cancer \[[@r21], [@r25], [@r41]\]. The oxidative damage can be protected by enzymatic antioxidants, including superoxide dismutase (SOD), glutathione peroxidase (GPX) and catalase (CAT), and non-enzymatic mechanisms by low molecular mass compounds such as glutathione, ascorbic acid, α-tocopherol and carotenoids \[[@r15]\]. The function of enzymatic antioxidants is to prevent the ROS from attacking other essential proteins in the cell by converting oxidative products into non dangerous molecules by multi-step processes, while the activity of non-enzymatic antioxidants is to interrupt free radical chain reactions and neutralize the ROS in a process called radical scavenging \[[@r31]\]. One of the key anti-oxidative enzymes, SODs, is a family of enzymes that are important for the biological defense of cell injuries mediated through oxygen free radicals. The three main SOD isoforms have been identiﬁed in mammalian cells with different localization: the cytosolic Cu/Zn-SOD (SOD1), mitochondrial Mn-SOD (SOD2) and extracellular Cu/Zn-SOD (SOD3). They detoxify superoxide ion and change into hydrogen peroxide which is inactivated by CAT into oxygen and water which are not harmful for cells. In hepatocyte, SOD1 expression is in the cytoplasm, followed by inside the nucleus. Its distribution was clarified to overlap with the site of superoxide production. High concentration of SOD1 was found in lysosome by nonselective autophagy since it is resistant to protease digestion. Surprisingly, the endoplasmic reticulum (ER) does not contain remarkable concentrations of SOD1 because the production of superoxide is on the cytoplasmic side which towards the surrounding cytoplasm whereas it is very low inside the ER cisternae. In mitochondria, the superoxide is formed by electron released from electron transport chain, but SOD2 plays major protective role in this part instead of SOD1 \[[@r6], [@r9]\].

Astaxanthin (AX) (3,3′-dihydroxy-β, β-carotene-4,4′-dione) is a red carotenoid pigment found in microorganisms such as the green algae *Haematococcus pluvialis* \[[@r36]\], the red yeast *Phaffia rhodozyma* \[[@r7]\], and in many marine animals \[[@r43]\]. It has been used as a feed supplement to promote growth, egg quality, muscle and yolk pigmentation, immune system and antioxidant capacity in livestock, especially aquatic animals and poultry \[[@r35], [@r43]\]. AX has been reported as a powerful non-enzymatic antioxidant for scavenging variety of free radicals. Its antioxidative activity is 10 times stronger than zeaxanthin, lutein, tunaxanthin, canthaxanthin and β-carotene, and 100 times greater than α-tocopherol \[[@r26], [@r29]\]. AX can protect acute CCl~4~ induced liver damage by inhibiting lipid peroxidation and increasing antioxidative mechanism by stimulating glutathione and SOD activities \[[@r20]\]. It prevents liver fibrosis by suppressing multiple profibrogenic factors in mice \[[@r39]\]. Moreover, AX also has anti-inflammatory activity by suppressing the level of NF-kB which regulates the production of inflammatory mediators \[[@r22]\]. Although AX has been widely studied for its hepatoprotective property, the investigation of AX activity on liver protection prior to an acute AFB~1~ administration in rat has never been studied. In present study, we focused on histopathological changes and immunohistochemistry of SOD1 in AFB~1~ intoxicated rats by comparing the two doses of 5 mg/kg or 100 mg/kg AX. Since the climate in Southeast Asia is suitable for the growth of *Aspergillus* spp., contamination of AFB~1~ has been found frequently during the processes of human and animal food production. Therefore, this study will be beneficial for the preventive treatment of aflatoxicosis in human and animal in the future.

MATERIALS AND METHODS {#s1}
=====================

Animals
-------

A total of 20 male Wistar rats, 6-week-old, weighing 200--250 g were obtained from National Laboratory Animal Center (Nakhon Pathom, Thailand). All rats were acclimated at 22--25°C in 12 hr dark/light cycle and fed *ad libitum.* This study has been approved by the Institutional Animal Care and Use Committee of Kasetsart University, Thailand (ID\# ACKU 61-VET-023).

Chemicals and preparation
-------------------------

Aflatoxin B~1~ (Sigma-Aldrich, St. Louis, MO, U.S.A.) was dissolved in 50% (w/v) DMSO in distilled water to the final concentration of 1 mg/kg and fed for each rat \[[@r34]\]. AstaMax^®^10S (Guangzhou Juyuan Bio-Chem Co., Ltd., Guangzhou, China), 10% astaxanthin in calcium lignosulfonate, was daily prepared by dissolving in warm water as recommended by manufacturer into dosages of 5 mg/kg astaxanthin for low dose administration and 100 mg/kg astaxanthin for high dose administration \[[@r20]\]. Mouse monoclonal anti-SOD1 antibody, HRP-conjugated mouse IgG kappa chain binding protein (m-IgGκ BP-HRP), goat polyclonal anti-GAPDH antibody and HRP-conjugated donkey anti-goat IgG antibody were purchased from Santa Cruz Biotechnology, Inc., Dallas, TX, U.S.A. DAB peroxidase substrate kit was purchased from Vector Laboratories, Inc., Burlingame, CA, U.S.A.

Experimental design
-------------------

The experimental animals were randomly divided into 4 groups of 5 rats: Control group (normal rats without AFB~1~ intoxication and AX treatment), AFB~1~ group (rats intoxicated by AFB~1~), AXL+AFB~1~ group (rats treated with low dose AX before AFB~1~ intoxication) and AXH+AFB~1~ group (rats treated with high dose AX before AFB~1~ intoxication). The rats in control and AFB~1~ groups were gavaged with 2 m*l* of distilled water for 7 days. At day 8, control rats were received 2 m*l* of 50% DMSO in distilled water whereas rats in AFB~1~ group were received 1 mg/kg AFB~1~. The rats in AXL+AFB~1~ and AXH+AFB~1~ groups were gavaged for 7 days with 5 mg/kg and 100 mg/kg astaxanthin, respectively. Then, both groups were also received 1 mg/kg AFB~1~ at the 8th day. All rats were fed for the following 4 days and were euthanized at the 13th day by intraperitoneal injection with 60 mg/kg pentobarbital sodium and blood and liver tissue samples were then collected. During the experiment periods, the rats were weighed every day to observe weight gain.

Serum biochemistry
------------------

The blood samples were obtained from the experimental rats by cardiac puncture. The serum was separated and measured the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) by automated chemistry analyzer (Mindray^®^ BS 380, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shenzhen, China).

Histopathological examination
-----------------------------

Entire liver was removed from each rat and weighed. The ratio of liver weight/100 g body weight (LW/100 g BW) was calculated. The liver tissue for histopathological study was cut and fixed in 10% neutral buffered formalin, dehydrated in graded alcohol series, cleared in xylene and embedded in paraffin. Tissue sectioning was done at 3 *µ*m thickness and stained with hematoxylin and eosin (H&E). The histopathological observation was performed by Olympus^®^ BX50 light microscope (Olympus Corp., Tokyo, Japan). The photographs of 40× magnification were taken and the cell numbers of hepatocyte alterations were counted for 20 randomized areas of a square millimeter (mm^2^).

Immunohistochemical staining
----------------------------

Paraffin sections of liver were deparaffinized, rehydrated and incubated in 10 mM citrate buffer (pH 6.0) at 95°C for antigen retrieval. Non-specific binding was blocked with 2% bovine serum albumin (BSA) in phosphate buffered saline (PBS). Mouse monoclonal anti-SOD1 antibody at a dilution of 1:500 was overnight incubated on liver tissue at 4°C. The tissues were washed with 0.05% Tween 20 in PBS (pH 7.4) and incubated with 3% hydrogen peroxide to inactivate endogenous peroxidase. The m-IgGκ BP-HRP at a dilution of 1:1,000 was applied and immunoreactivity of SOD1 was visualized by DAB peroxidase substrate kit. The tissue sections were then counterstained with hematoxylin and observed under light microscope.

Western blot analysis
---------------------

The liver tissue was snap frozen by liquid nitrogen and kept in −80°C refrigerator. Total protein was extracted from homogenized tissue in RIPA buffer containing protease inhibitor cocktail (Sigma-Aldrich). The supernatant was collected after centrifugation at 13,000 rpm for 20 min at 4°C. The protein concentrations of each sample were measured using Bio-Rad Protein Assay Dye Reagent Concentrate (Bio-Rad Laboratories, Inc., Hercules, CA, U.S.A.) and analyzed by Synergy H1 Hybrid Multi-Mode Microplate Reader with Gen5^TM^ 2.0 Data Analysis Software (BioTek^®^, Winooski, VT, U.S.A.). The samples containing 25 *µ*g of total protein were separated by 12.5% SDS-PAGE (100V for 90 min) and then transferred into nitrocellulose membrane by constant voltage of 100V for 1 hr at 4°C. The non-specific protein binding on the membrane was blocked with 5% non-fat milk in TBST and the membrane was then incubated with mouse monoclonal anti-SOD1 antibody (1:2,000 dilution). After washing with TBST, the membrane was incubated with m-IgGκ BP-HRP (1:5,000 dilution). The bands were detected by enhanced chemiluminescence (ECL) (Clarity^TM^ Western ECL Substrate), visualized by ChemiDoc^TM^ Imaging System and analyzed by Image Lab^TM^ Software (version 6.0) (Bio-Rad Laboratories, Inc.). The same membrane was immersed in stripping buffer at 50°C for 30 min. The non-specific protein was blocked with 5% BSA and the membrane was reprobed with goat anti-GAPDH antibody (1:1,000 dilution) and HRP-conjugated anti-goat IgG antibody (1:5,000 dilution) as an internal control.

Data analysis
-------------

The average values of body weight gains, LW/100 g BW, liver enzyme parameters, numbers of hepatocyte alterations and normalized densitometry of SOD1/GAPDH from western blot analysis were presented as mean ± standard deviation (SD). The percentage of SOD1 stained area was measured by Image J (version 1.52a, National Institute of Health, Bethesda, MD, U.S.A.) from 5 different areas in each group and averaged to evaluate the density of SOD1 immunoreactivity. All data were analyzed by using Kruskal-Wallis test followed by Dunn's *post hoc* test. The R statistical software for Windows (version 3.5.0., R Core Team) was used to analyze statistical significance with an acceptable level at *P*≤0.05.

RESULTS {#s2}
=======

Effect of AX and AFB~1~ on body weight
--------------------------------------

During the experimental period, none of the rats showed any signs of illness. All rats were daily weighed and their body condition was examined for health assessment. The variation of average body weight gain in rats of all groups either before or after AFB~1~ intoxication showed no significance. Interestingly, the rats in AXH+AFB~1~ group that have been gavaged by high dose AX for 7 days before AFB~1~ administration gained less weight than others. However, the weight gain of rats in AFB~1~ group became lowest after AFB~1~ intoxication ([Table 1](#tbl_001){ref-type="table"}Table 1.Average body weight gain before and after aflatoxin B~1~(AFB~1~) intoxicationGroupBody weight gain (g)Before AFB~1~ (d1-d7)After AFB~1~ (d9-d13)Control50 ± 7.0722 ± 11.51AFB~1~38.75 ± 2.5013.75 ± 4.79AXL+AFB~1~37 ± 8.3718.33 ± 10.41AXH+AFB~1~33.33 ± 11.5520 ± 14.14Data is presented as mean ± SD. AXL: low dose astaxanthin, AXH: high dose astaxanthin.).

Effect of AX and AFB~1~ on liver weight (LW)
--------------------------------------------

At 13th day, all rats were weighed and then euthanized to collect liver samples. An average body weight of rats in all groups showed no significant difference. However, the LW was significantly increased in AFB~1~ group, while it was not different among control, AXL+AFB~1~ and AXH+AFB~1~ groups. The calculation of LW/100 g BW manifested significantly higher value in AFB~1~ group when compared to control and both AX treated groups ([Table 2](#tbl_002){ref-type="table"}Table 2.Average liver weight (LW), body weight (BW) and LW/100 g BWGroupLW (g)BW (g)LW/100 g BWControl9.71 ± 0.14^a)^242.50 ± 13.234 ± 0.24^a)^AFB~1~11.50 ± 0.54^b)^241.25 ± 20.974.83 ± 0.26^b)^AXL+AFB~1~9.72 ± 0.70^a)^225 ± 9.134.33 ± 0.28^a)^AXH+AFB~1~9.74 ± 0.87^a)^226.67 ± 15.284.27 ± 0.12^a)^Data is presented as mean ± SD. a, b) indicate significant difference within a column (*P*\<0.05). AFB~1:~ aflatoxin B~1~, AXL: low dose astaxanthin, AXH: high dose astaxanthin.).

Effects on liver function evaluated by serum ALT and AST levels
---------------------------------------------------------------

All experimental groups showed elevated serum ALT and AST as compared to control ([Table 3](#tbl_003){ref-type="table"}Table 3.Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels of experimental rats in each groupGroupALT (U/*l*)AST (U/*l*)Control24 ± 9.08^a)^68.80 ± 29.23AFB~1~57.67 ± 26.10^b)^122.33 ± 33.50AXL+AFB~1~25.67 ± 7.64^a)^78 ± 28.69AXH+AFB~1~42 ± 9.90^a)^143.50 ± 54.45Data is presented as mean ± SD. a, b) indicates significant difference within a column (*P*≤0.05). AFB~1~: aflatoxin B~1~, AXL: low dose astaxanthin, AXH: high dose astaxanthin.). Especially, the level of serum ALT in AFB~1~ group was significantly increased whereas this parameter revealed no significant difference from control in AXL+AFB~1~ and AXH+AFB~1~ groups. Nevertheless, average AST level of rats in control, AFB~1~, AXL+AFB~1~ and AXH+AFB~1~ groups was not statistically different.

Liver histopathological findings
--------------------------------

The histopathological changes of liver tissue occurred in all experimental groups apart from control rats, which revealed normal pattern of hepatic cord arrangement in hepatic lobules with intact portal areas ([Fig. 1a](#fig_001){ref-type="fig"}Fig. 1.The illustration of histopathological findings of rat liver in control group (a) showed normal histology which some megalocytes, binucleated hepatocytes and apoptotic cells could be noticed (b). Liver tissue from AFB~1~ group (c) revealed massive vacuolar degeneration in all lobules and bile duct hyperplasia in portal area. Megalocytes, binucleated hepatocytes and their degenerated forms as well as necrotic cells that underwent karyorrhexis were extensively found in this group (d). The vacuolar degeneration of hepatocytes was gradually reduced from AXL+AFB~1~ group to AXH+AFB~1~ group (e and g). The appearance of megalocytes and binucleated cells was still high in AXL+AFB~1~ group (f). Necrotic and apoptotic cells were slightly observed in AXL+AFB~1~ and AXH+AFB~1~ groups (h). Thick arrow; Megalocyte, Black arrowhead; Binucleated hepatocyte, Black thin arrow; Degenerative binucleated hepatocyte, White thin arrow; Necrotic cell (karyorrhexis), White arrowhead; Apoptotic cell. AFB~1~: aflatoxin B~1~, AXL: low dose astaxanthin, AXH: high dose astaxanthin. H&E. Bar in a, c, e, g=200 *µ*m, Bar in b, d, f, h=50 *µ*m.). Besides normal hepatocytes, some megalocytic, binucleated and apoptotic hepatocytes were also presented in control group. The apoptotic cells were smaller than adjacent cells and showed hypereosinophilic cytoplasm from cytoplasmic condensation with pyknotic or fragmented nuclei \[[@r13]\] ([Fig. 1b](#fig_001){ref-type="fig"}). After receiving 1 mg/kg AFB~1~ for 4 days, massive vacuolar degeneration of hepatocytes were found in all hepatic lobules of rats from AFB~1~ group. Some hepatocytes underwent karyorrhexis and some degenerated cells exhibited really faint or nuclei absent (karyolysis) which indicated necrosis ([Fig. 1c and 1d](#fig_001){ref-type="fig"}). Various degrees of typical bile duct hyperplasia and inflammatory cell infiltration were observed in all portal areas. Acidophilic megalocytes and binucleated hepatocytes were distributed in all lobules, though some of them had been degenerated ([Fig. 1d](#fig_001){ref-type="fig"}). The rats in AXL+AFB~1~ group gavaged by 5 mg/kg AX for 7 days before AFB~1~ intoxication revealed different results compare with the AFB~1~ treatment group. The vacuolar degenerative hepatocytes were found at periportal area, but were extended into midzonal to centrilobular areas in some lobules ([Fig. 1e](#fig_001){ref-type="fig"}). The amount of megalocytes, binucleated cells and inflammatory cell infiltration were approximately equal to AFB~1~ group ([Fig. 1f](#fig_001){ref-type="fig"}), whereas bile duct hyperplasia was low. Noteworthy, one rat from this group showed distinct appearance of hypertrophic hepatocytes with extensive basophilic cholangiocyte proliferation. The vacuolar degenerative hepatocytes were rarely noticed in this rat. These hypertrophic cells were approximately two times larger in size when compared with normal hepatocyte, leading to disarrangement of hepatic cord. The sinusoids in these areas were narrowed. Some cells showed abnormal large sized nucleus and some were binucleated, but most cells possessed increasing cellular content but normal nuclear sizes with irregular cytoplasmic clumping below the plasma membrane and vesicular pattern of nuclei ([Fig. 2](#fig_002){ref-type="fig"}Fig. 2.Hypertrophic hepatocytes associated with proliferation of cholangiocytes (gray arrows) revealed in some rats of AXL+AFB~1~ and AXH+AFB~1~ groups (this picture is representative fom AXH+AFB~1~ group). Few hepatocytes showed abnormal large sized nucleus (megalocytes; black arrows) but most cells possessed increasing cellular content but normal nuclear size. H&E. AXL: low dose astaxanthin, AXH: high dose astaxanthin, AFB~1~: aflatoxin B~1~. Bar=50 *µ*m.). In AXH+AFB~1~ group, one rat showed hepatic vacuolar degeneration and typical bile duct hyperplasia at periportal and midzonal areas with less severity than in AXL+AFB~1~ group ([Fig. 1g and 1h](#fig_001){ref-type="fig"}) but the others revealed predominant hypertrophic hepatocytes and cholangiocyte proliferation. Among these four rats in AXH+AFB~1~ group, half of them showed slight hepatic vacuolar degeneration, but this occurrence was not existed within any lobules in another half. The mean value of all hepatocyte alterations in control group was the lowest except the number of apoptotic cells which was insignificantly higher than in AFB~1~ and AXL+AFB~1~ group. The degeneration and necrosis were remarkably high in AFB~1~ group compared to other groups (*P*\<0.05). Moreover, the AXL+AFB~1~ group also showed significantly notable level of hepatocyte degeneration from AXH+AFB~1~ group. The number of megalocyte was higher in AFB~1~ and AXL+AFB~1~ group than in AXH+AFB~1~ group (*P*\<0.05) while the binucleated cells in AFB~1~ group was lower than in AXL+AFB~1~ and AXH+AFB~1~ groups (*P*\<0.05). The AXH+AFB~1~ group revealed low amount of necrotic cells which was not significantly different from control but the level was elevated in AXL+AFB~1~ group (*P*\<0.05). In contrast, the amount of apoptotic cells was high in AXH+AFB~1~ group implying that the irreversibly degenerative cells in AXH+AFB~1~ group were subjected to be eliminated by apoptosis instead of necrosis. The highest level of hypertrophic hepatocytes was also apparently observed in AXH+AFB~1~ group though there was no significant difference among groups ([Table 4](#tbl_004){ref-type="table"}Table 4.Effects of aflatoxin B~1~ (AFB~1~) and astaxanthin on hepatocyte alterationsGroupAverage cell number per square millimeter (cells/mm^2^)Vacuolar degenerativeMegalocyticBinucleatedNecroticApoptoticHypertrophicControl12.3 ± 15.9^a)^7.9 ± 10.8^a)^44.6 ± 30.6^a)^2.0 ± 5.3^a)^2.5 ± 5.00.0 ± 0.0AFB~1~747.8 ± 229.7^b)^54.6 ± 54.5^b)^77.6 ± 31.2^b)^117.8 ± 62.0^b)^0.9 ± 3.30.9 ± 3.3AXL+AFB~1~488.4 ± 330.4^c)^48.5 ± 31.4^b)^93.9 ± 39.2^c)^42.2 ± 35.6^c)^1.8 ± 7.22.0 ± 7.2AXH+AFB~1~47.7 ± 42.9^d)^26.2 ± 19.8^c)^91.8 ± 36.9^c)^5.2 ± 7.7^a)^3.2 ± 6.232.5 ± 26.8Data is presented as mean ± SD. a--d) indicates significant difference within a column (*P*\<0.05). AXL: low dose astaxanthin, AXH: high dose astaxanthin.).

Immunohistochemistry and expression of SOD1
-------------------------------------------

The SOD1 immunostaining of liver cells in control group revealed of dark brown color either in cytoplasm or nuclei ([Fig. 3a](#fig_003){ref-type="fig"}Fig. 3.Superoxide dismutase 1 (Cu/Zn-SOD: SOD1) Immunoreactivity demonstrated an expression in hepatocytes of (a) control, (b) AFB~1~, (c) AXL+AFB~1~ and (d) AXH+AFB~1~ groups. The other types of cell, such as Kupffer cells and endothelial cells, were stained blue from hematoxylin dye. AFB~1~: aflatoxin B~1~, AXL: low dose astaxanthin, AXH: high dose astaxanthin. Bar=50 *µ*m.) whereas degenerative cells in AFB~1~ group were stained only at nuclei and edge of cells and the necrotic cells were unstained. Very few cells were fully stained in the cytoplasm ([Fig. 3b](#fig_003){ref-type="fig"}). For AXL+AFB~1~ group, the hepatocytes displayed variety of immunoreactivity but mostly were illustrated as moderate brown staining ([Fig. 3c](#fig_003){ref-type="fig"}). The higher immunostaining was seen in hepatocytes of AXH+AFB~1~ group, which were filled by visible dark brown color ([Fig. 3d](#fig_003){ref-type="fig"}). The percentage of brown staining area from each group was quantified to indicate differences of SOD1 expression level. The SOD1 immunostaining from control, AFB~1~, AXL+AFB~1~ and AXH+AFB~1~ groups was shown as 37.61, 31.47, 33.16 and 35.43%, respectively. The analysis of these measurement implied that SOD1 expression in hepatocytes of AXH+AFB~1~ group was significantly elevated comparing to AFB~1~ and AXL+AFB~1~ groups. Control group significantly presented the highest level of SOD1 immunostaining whereas the percentage of staining area between AFB~1~ and AXL+AFB~1~ groups was not significantly different ([Fig. 4](#fig_004){ref-type="fig"}Fig. 4.Percentage of superoxide dismutase 1 (Cu/Zn-SOD: SOD1) immunostained area from control, AFB~1~, AXL+AFB~1~ and AXH+AFB~1~ groups. AFB~1~: aflatoxin B~1~, AXL: low dose astaxanthin, AXH: high dose astaxanthin. \*,\*\*,\*\*\* indicate significant difference among groups.). The western blot analysis was performed in order to confirm whether AX could induce expression of SOD1 in AFB~1~ ingested rat as shown in immunohistochemistry. The result manifested that SOD1 expression was slightly increased in AXH+AFB~1~ group from the control but markedly declined in AFB~1~ group (*P*\<0.05). However, the expression level of SOD1 was not much different between AFB~1~ and AXL+AFB~1~ groups ([Fig. 5](#fig_005){ref-type="fig"}Fig. 5.Western blot analysis of liver extract containing 25 *µ*g of protein in each lane to detect superoxide dismutase 1 (Cu/Zn-SOD: SOD1) and Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) band density. Normalized densitometric values of SOD1/GAPDH, presented as mean ± SD, indicated that the SOD1 expression level in AXH+AFB~1~ group was significantly higher than that in AFB~1~ group (*P*\<0.05). AFB~1~: aflatoxin B~1~, AXL: low dose astaxanthin, AXH: high dose astaxanthin. a and b indicate significant difference among groups.).

DISCUSSION {#s3}
==========

Although the body weight gain in all groups was not significantly different during the first week of experimental period, the declined weigh and food intake of rats in AXH+AFB~1~ group has been noticed. No sign of illness was examined in these rats. Since the AX used in this experiment is a feed additive grade for aquatic animals, it was 10% mixture with calcium lignosulfonate to facilitate the administration into water-based foods. We speculate that highly viscous ingredients might completely fill in rat stomach and alleviate appetite. Indeed, an overdose of vitamin A has been known to induce appetite loss and growth reduction \[[@r24]\], but an AX dosage of 100 mg/kg has been orally administered in rats for 15 days without any adverse effect \[[@r20]\]. Therefore, the dosage used in this study might not high enough to promote toxicity. After AFB~1~ gavage, the difference of body weight gain between groups was also insignificant. Nevertheless, an average weight gain of rats from AFB~1~ group was obviously less than others, whereas the AXH+AFB~1~ group was elevated. Qian *et al.* (2013) showed similar result in the toxicological study of AFB~1~ exposure in rats, but the body weight gain of 1 mg/kg AFB~1~ exposed rats was significantly decreased when compared to the control \[[@r34]\]. This result implies that AX could help to enhance body weight in rats receiving AFB~1~.

An average LW and LW / 100 g BW of rats in AFB~1~ group was significantly higher than other groups, while those of rats in control, AXL+AFB~1~ and AXH+AFB~1~ groups showed little difference. From our study, the acute intoxication of high dose AFB~1~ recruited inflammatory response in liver tissue which was shown as inflammatory cells infiltration around portal areas. This occurrence was also consistent with reports of some studies indicating that an increased liver weight was subsequently a result from massive liver inflammation \[[@r20], [@r34]\]. Noteworthy, the insignificant difference of average LW and LW / 100 g BW between control and both of AX treated groups implies that AX possessed an anti-inflammatory potential in rat liver towards acute AFB~1~ intoxication. Previous studies revealed that AX reduces pro-inflammatory cytokines which cause liver damage by a toxic dose of acetaminophen, such as TNF-α and IL-6, within 24 hr \[[@r50]\]. Beside the inhibition of acute inflammation, AX also inhibits chronic inflammation which could induce hepatic fibrosis by decreasing of TGF-β1 expression via down regulation of NF-κB \[[@r22], [@r39]\].

AX could restore liver function from AFB~1~ induced destruction as inspected by the significantly declining level of ALT in rats received AX for 1 week before AFB~1~ intoxication ([Table 3](#tbl_003){ref-type="table"}). The AST level, despite no statistically significant difference among groups, the level in AXH+AFB~1~ group was only slightly different from AFB~1~ group, whereas this enzyme in AXL+AFB~1~ group had almost similar level to control group. It is surprising that an equal dosage of AX used significantly reduced serum ALT and AST levels in CCl~4~ induced rats \[[@r20]\], although we gave half shorter duration of AX treatment before inducing hepatocellular damage by AFB~1~. We also suspect whether calcium lignosulfonate might have hepatotoxic action since its high concentration has been mixed with AX and gavaged into rats in this group. However, this hypothesis might be untrue because this polymer of lignin is considered safe as a feed additive in animals \[[@r12]\]. As a result of its high molecular weight, calcium lignosulfonate is poorly absorbed from the gastrointestinal tract of rats. In addition, the *in vitro* studies also show low transepithelial transport in Caco2 cells. Therefore, the presence of substantial amount of this compound in the tissues is unlikely \[[@r11]\]. Furthermore, the JECFA set an acceptable daily intake of calcium lignosulfonate, based on a 90-day rat study, at a dosage up to 2,000 mg/kg body weight \[[@r19], [@r42]\]. Accordingly, such amount of calcium lignosulfonate given to rats in AXH+AFB~1~ group is not possible to cause hepatotoxic. Moreover, it was also confirmed that the causation of the lowest weight gain of rats in AXH+AFB~1~ group in the first period of our experiment was from an indigestible calcium lignosulfonate as described above.

The AFB~1~ is known to have hepatotoxic potency. In this study, massive degeneration, necrosis, magalocytosis, and binucleation of hepatocytes were induced in the liver of rats administered a high single dose of AFB~1~ ([Fig. 1c and 1d)](#fig_001){ref-type="fig"}. These incidences were found throughout the hepatic lobules but mostly localized at periportal to midzonal areas. The finding is similar to a report of Qian *et al.* (2013) \[[@r34]\] but contrast to the chronic intoxication by repeating low dosage of AFB~1~ which hydropic degeneration was primarily detected at centrilobular (periacinar) and midzonal regions of hepatic lobules \[[@r48]\]. The hepatocytes residing around centrilobular area own the highest concentration of microsomal cytochrome P450 which activates AFB~1~ metabolism to produce a highly reactive intermediate, the 8, 9-epoxide metabolite \[[@r10], [@r41]\]. Therefore, the centrilobular hepatocytes tend to be more sensitive to AFB~1~ induced liver damage than the periportal ones. Nevertheless, the AFB~1~ from intestinal absorption is circulated in portal vein located in portal area before distributing toward the centrilobular region. We speculate that, after oral administration with high dose AFB~1~, the amount of AFB~1~ predominantly concentrated and metabolized in periportal and midzonal hepatocytes was high enough to immediately degenerate and destroy cells. Thus, the vacuolar degeneration and necrosis of hepatocytes were mainly focused in these areas instead of centrilobular region. The ROS produced from AFB~1~ metabolism affect cell membrane integrity leading to calcium influx and cell swelling as the initial process of vacuolar degeneration \[[@r8]\]. This pathological change was declined in AXL+AFB~1~ group ([Fig. 1e and 1f)](#fig_001){ref-type="fig"} and obviously reduced in AXH+AFB~1~ group ([Fig. 1g and 1h)](#fig_001){ref-type="fig"} indicating the protective effects of AX to the cell from degenerative process. The damage of cell membrane is primarily activated by peroxyl radical generated in the process of lipid peroxidation, and carotenoids are known the efficient scavenger for this ROS \[[@r31]\]. Therefore, AX should certainly have scavenging efficacy against peroxyl radical as in other carotenoids. Besides cellular degeneration and necrosis, megalocytosis and binucleation of hepatocytes were also noted in all groups especially in AFB~1~ administered groups. Since aflatoxin has antimitotic effect, though less capable than pyrrolizidine alkaloid, the replacement of AFB~1~ damaged hepatocytes by naturally proliferation is limited, especially in the prolonged aflatoxicosis \[[@r10], [@r30]\]. As a result, the cellular and nuclear enlargement of cell displaying active DNA and protein synthesis but impaired cell division is occurred, so called megalocytosis \[[@r3]\]. However, the feasibility of megalocyte as a precancerous cell is not confirmed although the study of liver carcinogenesis in Wistar rats with a single dose of 7 mg/kg AFB~1~ or subsequently repeated CCl~4~ inhalation demonstrates that megalocytosis is the first observed lesion and the tumor cells usually located among the megalocytic cells \[[@r38]\]. In another aspect, polyploidy, which is usually found as megalocyte and binucleated cell, could also denote an adaptive mechanism to become more resistant to oxidative stress and genotoxic damage from xenobiotic \[[@r4], [@r14], [@r17], [@r28]\]. Several researchers elucidated that diploid hepatocytes enter the cell cycle faster than polyploid cells. Moreover, multiple copies of tumor suppressors in polyploid hepatocytes reduce the likelihood of transformation, whereas diploid hepatocytes have only two copies and are prone to tumorigenesis by inactivating mutation of these genes. These advantages of polyploidy eventually reduce the expansion of transformed genes into the progeny \[[@r14], [@r46]\]. According to our result, we hypothesized that increased megalocyte in AFB~1~ ingested rat was due to dual causation, AFB~1~ toxicity and adaptation to toxin. AX treated groups exhibited less number of megalocyte than in AFB~1~ group because it could alleviate AFB~1~ toxicity. Meanwhile, the adaptive response in AX treated groups shown as polyploidy led to higher number of binucleated hepatocyte ([Table 4](#tbl_004){ref-type="table"}).

The bile duct hyperplasia exhibited in AFB~1~ group was a typical proliferation of cholangiocytes which demonstrated as newly formed bile ducts with well-defined lumens \[[@r23]\]. This is relevant to an observation from Qian *et al.* (2013) in rats orally administered by 1 mg/kg AFB~1~ \[[@r34]\]. In AXL+AFB~1~ group, most rats also showed similar morphology of bile duct hyperplasia, except one rat that revealed cholangiocyte proliferation originated at portal area and extended into surrounding hepatic parenchyma coincided with hypertrophy of hepatocytes ([Fig. 2](#fig_002){ref-type="fig"}). The same incidence was also noted in most rats from AXH+AFB~1~ group. This atypical cholangiocyte proliferation was supposed to be a ductular reaction to restore the nearby damaged hepatocytes during liver injury. The regeneration is arisen from transdifferentiation of proliferated cholangiocytes into hepatocytes \[[@r37]\]. In acute liver injury, destroyed hepatocytes are replaced by β-catenin dependent proliferation of neighboring alive hepatocytes. However, the β-catenin dependent regenerative response is impaired in case of severe or chronic injury. Thus, the hepatocyte repopulation will be relied on β-catenin independent cholangiocyte-to-hepatocyte differentiation that will be occurred after damaging causes have been eradicated \[[@r32]\]. AX is well documented for its anti-oxidative activity. The elimination of free radicals and ROS generated from AFB~1~ metabolism is considered to remove cause of liver damage, leading to improvement of liver tissue by atypical cholangiocytes proliferation, as seen in some rats from AXL+AFB~1~ and AXH+AFB~1~ groups. Ultimately, these cells will be derived into hepatocytes. Moreover, the hepatocytes predominantly found in these rats showed the morphology of hypertrophy with cytoplasmic clumping and vesicular nucleus. According to a review of Hall *et al*. (2012), an increased size of liver cell could be resulted from elevated protein production and proliferation of subcellular organelles typically sER and/or peroxisome. From the experiment of microsomal enzymes inducer administration in rats, the hypertrophy of hepatocytes was examined through smooth ER proliferation observed by electron microscopic study which demonstrated characteristic stacks of smooth ER that crowd out other organelles. Some xenobiotics also induce peroxisome proliferation which presented as catalase positive electron dense vesicles in the cytoplasm. Importantly, both circumstances are considered adaptive and non-adverse responses to induce hepatic metabolism. However, these responses can be failed at higher dose levels or following prolonged exposure, if degenerative changes of hepatocytes are overcome or novel cytotoxic metabolites are generated \[[@r16]\]. These data supports our observations, especially in AXH+AFB~1~ group, revealing hepatocyte hypertrophy which was suspected to contain cytoplasmic proteins with accumulation of multiplied organelles involving production of those anti-oxidative enzymes ([Table 4](#tbl_004){ref-type="table"}). Moreover, the higher serum ALT level, but not above two times than control, in AXH+AFB~1~ group might indicate a consequence of increased enzyme synthesis, as also noted by Hall *et al*. (2012) \[[@r16]\].

In the liver, the AFB~1~ toxicity through AFB~1~-8, 9-epoxide causes generation of intracellular ROS leading to oxidative stress and damage of vital components such as DNA and cell membrane \[[@r21], [@r25], [@r27]\]. The cellular anti-oxidative activities are deprived in 1 mg/kg AFB~1~ administered rats as shown by increasing lipid peroxidation and decreased various anti-oxidative enzymes, such as SOD, CAT, GPX and glutathione-S-transferase \[[@r33]\]. SOD has been shown to have a protective effect on liver injury induced by AFB~1~ \[[@r20], [@r27], [@r40], [@r48], [@r49]\]. It is responsible for the first line of antioxidant defensive system against cell injury from the highly ROS generated by biochemical redox reactions in normal cell metabolism, and by exogenous sources. The SOD1 expression is stronger in normal liver tissue comparing to hepatocellular carcinoma in the same patient. However, superoxide radicals and other ROS generated in malignant cells are probably diffuse into surrounding tissue and further damaging it. The up-regulation of SOD and other antioxidative enzymes is likely the mechanism to resist the damage from increasing oxidative stress in hepatocyte \[[@r45]\]. SOD1 is ascribed to be synthesized by ribosomes. Its distribution in the cytosol is unsuspicious but the existence in nuclear matrix is believed to occur by diffusion of cytosolic SOD1 into the nucleus through nuclear pores \[[@r6]\]. The localization of SOD1 is corresponding to the finding from our present study. Additionally, our study obviously revealed the SOD1 expression decreased in the liver of rats in AFB~1~ group, whereas the expression of this enzyme in AXH + AFB~1~ group was significantly higher ([Figs. 4](#fig_004){ref-type="fig"} and[5](#fig_005){ref-type="fig"}). This result implies that AX potentially induces SOD1 expression as same as in previous reports \[[@r5], [@r20]\]. The similar result has been demonstrated in a study of curcumin hepatoprotective effects against aflatoxicosis. It was also found that curcumin stimulates up-regulation of anti-oxidative enzyme gene expression such as SOD and GPX. Additionally, curcumin also demonstrates other anti-oxidative activities by scavenging ROS through interaction within the oxidative cascade and inhibiting aflatoxin biotransformation by restriction of cytochrome P450, thus decreasing the formation of AFB~1~-8, 9-epoxide \[[@r27]\]. Though we did not intensively study for anti-oxidative effects of AX as in curcumin, the existing results are substantial to conclude that AX possesses hepatoprotective role in rat aflatoxicosis. The AFB~1~ generated ROS that consequently damaged hepatocytes as shown by elevated liver enzyme parameters and histopathological changes of vacuolar degeneration and cell necrosis. AX could alleviate cellular damage by diminishing degenerative and necrotic changes as well as serum ALT level in AXL+AFB~1~ and AXH+AFB~1~ groups. Some rats from AX treated groups also exhibited atypical proliferation of cholangiocytes which is believed to be a process of transdifferentiation to replace damaged hepatocytes. Likewise, both AX treated groups demonstrated higher percentage of SOD1 stained area when compared to AFB~1~ group. This result also corresponds to the western blot analysis indicating that SOD1 expression was induced by AX. However, the values in AXL+AFB~1~ group were not significantly different from AFB~1~ group, denoting that the AX induced SOD1 expression was dose dependent. The level of SOD1 expression in AXH+AFB~1~ group that was above the control could also verify increased activity of SOD1 production. Additionally, the hypertrophy of hepatocytes mostly found in rats receiving 100 mg/kg AX prior to AFB~1~ administration in AXH+AFB~1~ group may imply the over production of detoxifying proteins and accumulation of involving cytoplasmic organelles to mitigate AFB~1~ toxicity.
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